Viewing Study NCT06332950


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-28 @ 11:29 AM
Study NCT ID: NCT06332950
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-27
First Post: 2024-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
Sponsor: Baohui Han
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module